SEC filing · 8-K

BeyondSpring Inc.: Acquisition or sale completed

BeyondSpring completed the sale of BeyondSpring Ltd. to Biolin Investment Limited in exchange for funded clinical trial data.

Filed October 6, 2026

Mixed for the company

What happened

On September 30, 2026, BeyondSpring closed the sale of all share capital in BeyondSpring Ltd. to Biolin Investment Limited.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to BeyondSpring Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.